135 results on '"Hosono, Makoto"'
Search Results
2. Manual on the proper use of the 211At-labeled PSMA ligand ([211At]PSMA-5) for clinical trials of targeted alpha therapy (1st edition)
3. Clinical course of longer than five years after definitive radiotherapy for nasopharyngeal carcinoma
4. Effectiveness of shielding materials against 177Lu gamma rays and the corresponding distance relationship
5. Differentiating Brown Tumor From Bone Metastasis in Parathyroid Cancer Using 18F-FDG PET and 99mTc-MIBI SPECT
6. Occupational radiation exposure to the lens of the eyes and its protection during endoscopic retrograde cholangiopancreatography
7. Difference in failure patterns after stereotactic body radiotherapy for lung cancer according to clinical T stage based on 4D computed tomography
8. Novel nomogram developed for determining suitability of metastatic castration-resistant prostate cancer patients to receive maximum benefit from radium-223 dichloride treatment—Japanese Ra-223 Therapy in Prostate Cancer using Bone Scan Index (J-RAP-BSI) Trial
9. Steroids May Be Associated With Extensive Skeletal Muscle Uptake of 18F-FDG
10. Pembrolizumab-Associated Pneumonitis Resembling Lymphangitic Carcinomatosis in a Melanoma Patient
11. Manual on the proper use of meta-[211At] astato-benzylguanidine ([211At] MABG) injections in clinical trials for targeted alpha therapy (1st edition)
12. Visualization of tumor hypoxia and re-oxygenation after stereotactic body radiation therapy in early peripheral lung cancer: A prospective study
13. Impact of rectal gas on the planning target volume margin for pelvic bone and prostate matching in prostate cancer patients receiving volumetric-modulated arc therapy
14. Diagnostic Reference Levels for Fluoroscopy-guided Gastrointestinal Procedures in Japan from the REX-GI Study: A Nationwide Multicentre Prospective Observational Study
15. Safety and efficacy of peptide receptor radionuclide therapy with 177Lu-DOTA0-Tyr3-octreotate in combination with amino acid solution infusion in Japanese patients with somatostatin receptor-positive, progressive neuroendocrine tumors
16. Manual on the proper use of the 211At-labeled PSMA ligand ([211At]PSMA-5) for clinical trials of targeted alpha therapy (1st edition).
17. ペプチド受容体放射性リガンドを用いた膵NENの診断と治療
18. Manual on the proper use of sodium astatide ([211At]NaAt) injections in clinical trials for targeted alpha therapy (1st edition)
19. Differentiating Brown Tumor From Bone Metastasis in Parathyroid Cancer Using 18 F-FDG PET and 99m Tc-MIBI SPECT.
20. FDG-Avid Tracheal Mass and Cartilage Involvements in ANCA-Negative Granulomatosis With Polyangiitis
21. Effectiveness of shielding materials against 177Lu gamma rays and the corresponding distance relationship.
22. Assessing Therapeutic Response to Radium-223 with an Automated Bone Scan Index among Metastatic Castration-Resistant Prostate Cancer Patients: Data from Patients in the J-RAP-BSI Trial
23. Radiation dose and factors related to exceeding the diagnostic reference level in 496 transnasal ileus tube placement procedures from the REX-GI study
24. A follow‐up questionnaire survey 2022 on radiation protection among 464 medical staff from 34 endoscopy–fluoroscopy departments in Japan
25. Novel nomogram developed for determining suitability of metastatic castration-resistant prostate cancer patients to receive maximum benefit from radium-223 dichloride treatment—Japanese Ra-223 Therapy in Prostate Cancer using Bone Scan Index (J-RAP-BSI) Trial
26. Difference in failure patterns after stereotactic body radiotherapy for lung cancer according to clinical T stage based on 4D computed tomography
27. Questionnaire Report on the Independent Use of a Computed Tomography System Installed in the Room for High-dose-rate Remote Afterloading System
28. Impact of Knowledge-based Plan Model Improvement on Plan Complexity and Deliverability in VMAT For Prostate Cancer: A Multi-institutional Study
29. Investigation into the Optimal Strategy of Radium-223 Therapy for Metastatic Castration-Resistant Prostate Cancer
30. Radioactivity Concentration in the Air during Peptide Receptor Radionuclide Therapy with [177Lu]Lu-oxodotreotide
31. RADIATION EXPOSURE FOR GASTROINTESTINAL FLUOROSCOPIC PROCEDURES (REX-GI STUDY): A MULTICENTER PROSPECTIVE OBSERVATIONAL STUDY IN JAPAN
32. Comparison of Radiation Exposure between Endoscopic Ultrasound-Guided Hepaticogastrostomy and Hepaticogastrostomy with Antegrade Stenting
33. Escalated Maximum Dose in the Planning Target Volume Improves Local Control in Stereotactic Body Radiation Therapy for T1-2 Lung Cancer
34. How should radiation exposure be handled in fluoroscopy‐guided endoscopic procedures in the field of gastroenterology?
35. Measurement as a Personal Dose Equivalent of X-ray Room Scattered Dose in ERCP Inspection
36. Safety and Response after Peptide Receptor Radionuclide Therapy with 177 Lu‐DOTATATE for Neuroendocrine Tumors in Phase 1/2 Prospective Japanese Trial
37. Inverted papilloma originating from the lacrimal sac and the nasolacrimal duct with marked FDG accumulation
38. Cumulative radiation doses from recurrent PET–CT examinations
39. Comparison of radiation exposure between endoscopic ultrasound‐guided drainage and transpapillary drainage by endoscopic retrograde cholangiopancreatography for pancreatobiliary diseases
40. The radiation doses and radiation protection on the endoscopic retrograde cholangiopancreatography procedures
41. Manual on the proper use of meta-[211At] astato-benzylguanidine ([211At] MABG) injections in clinical trials for targeted alpha therapy (1st edition).
42. RADIATION EXPOSURE IN SELF-EXPANDABLE METALLIC STENT VS. TRANSANAL DECOMPRESSION TUBE PLACEMENTS FOR OBSTRUCTION OF COLORECATAL CANCER: A POST-HOC ANALYSIS OF REX-GI STUDY.
43. FDG-Avid Tracheal Mass and Cartilage Involvements in ANCA-Negative Granulomatosis With Polyangiitis
44. Serum lactate dehydrogenase is a predictive biomarker in patients with oropharyngeal cancer undergoing radiotherapy: Retrospective study on predictive factors
45. Activities to support individual dosimetry of children in Kawamata Town
46. 853 OCCUPATIONAL RADIATION EXPOSURE TO THE LENS OF THE EYES DURING ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP): A MULTICENTER PROSPECTIVE OBSERVATIONAL STUDY
47. Safety and response after peptide receptor radionuclide therapy with 177Lu‐DOTATATE for neuroendocrine tumors in phase 1/2 prospective Japanese trial.
48. Comparison of radiation exposure between endoscopic ultrasound‐guided drainage and transpapillary drainage by endoscopic retrograde cholangiopancreatography for pancreatobiliary diseases.
49. Safety and efficacy of peptide receptor radionuclide therapy with 177Lu-DOTA0-Tyr3-octreotate in combination with amino acid solution infusion in Japanese patients with somatostatin receptor-positive, progressive neuroendocrine tumors.
50. Manual on the proper use of sodium astatide ([211At]NaAt) injections in clinical trials for targeted alpha therapy (1st edition).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.